Clinical Decision Support Systems Market

Clinical Decision Support Systems Market size was valued at USD 1.91 Billion in 2023 and the total revenue is expected to grow at a CAGR of 9.1% through 2024-2030, reaching nearly USD 2.8 Billion.

Clinical Decision Support Systems Market Overview:

A clinical decision support system's goal is to assist healthcare providers by allowing them to analyse patient data and use that information to help them formulate a diagnosis. A clinical decision support system provides physicians and primary care providers with information to help them improve the quality of care they provide to their patients. Advanced CDSS, and Conventional CDSS are the types of the application of the clinical decision support systems. Integrated CDSS, and Standalone CDSS are the product types of the clinical decision support systems. Knowledge based, and Non-Knowledge based are the types of the model of the clinical decision support systems.To know about the Research Methodology:- Request Free Sample Report

Clinical Decision Support Systems Market Dynamics:

A medication error is a surprising failure in the drug treatment process that have a negative impact on patients' health. Prescription errors, dispensing errors, storage errors, preparation errors, and administration errors are the most common preventable causes of unwanted adverse outcomes, and they pose a significant public health threat. Patients and healthcare providers will receive better care if they have access to complete and accurate EHRs that have a complete patient illness history. Such records can help doctors make better diagnoses, avoid mistakes, save time, and even shorten patient wait times. For hospitals and clinicians to provide quality treatment, CDSS and its accompanying technologies must be implemented and used successfully, which is hastening their acceptance around the world.

Clinical decision support systems (CDSS) offers plenty of benefits such as patient safety, cost containment, administrative functions, diagnostics support, patient-facing decision support, clinical management, and so on. The growing need for lower healthcare costs, the need to improve the quality of service, and technical improvements in healthcare IT in hospitals are all expected to drive the clinical decision support systems (CDSS) market growth during the forecast period 2023-2030.

Besides, according to the Organization for Economic Co-operation and Development (OECD) survey report, Switzerland's average per capita health spending in 2018 was USD 7,317, Norway's was USD 6,187, and Australia's was USD 5,005. Because of the high cost of healthcare around the world, the growing demand to cut costs has a beneficial impact on the industry.

However, while CDSS are still in the early stages of development, a lack of faith in the systems, a scarcity of trained labour, and CDSS recommendations for superfluous diagnostic tests restrains the market growth during the forecast period 2023-2030.

Clinical Decision Support Systems Market Segment Analysis:

Based on the Product, the market is segmented into Integrated CDSS, and Standalone CDSS. Standalone CDSS segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2023-2030. This is due to its low cost and simplicity. The segment's rise has been aided by its ease of usage in hospitals and clinical settings. CDSS products can be used independently or in conjunction with an EHR or CPOE, or both.

During the forecast period 2023-2030, the integrated EHR with CDSS segment is expected to grow at a healthy rate. The growing use of EHR by multi-specialty health care units is expected to have an impact on the segment's growth. When CDS systems are coupled with EHR, CDSS receives the patient's database and history, allowing it to deliver clinical solutions and prescription recommendations to the practitioner, thereby automating the clinical workflow. CDSS and EHRs are frequently connected to improve workflows and make better use of existing data sets. The number of CDSS functions included into EHR systems is growing, which is expected to boost the segment's growth.

Based on the Delivery Mode, the market is segmented into On Premise, and Cloud based. Cloud based segment is expected to hold the largest market share of xx% by 2030. The rise of the cloud-based segment of the CDSS market is being driven by rising healthcare spending and the adoption of cloud computing. Nearly 95% of businesses use cloud-based applications. Different suppliers offer different hardware for electronic medical record (EMR) systems. As a result, creating a standard CDSS programme that can function on a variety of EMR systems is a huge undertaking.

CDSS local knowledge management may necessitate a significant amount of processing power and storage capacity, resulting in high running expenses. Cloud-based programmes, on the other hand, are run on remote servers and do not require a lot of processing power or storage space on the user's device to run.

Based on the Model, the market is segmented into Knowledge based, and Non-Knowledge based. Knowledge based segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2023-2030. The substantial share and rapid growth of this market can be ascribed to the many useful features of knowledge-based CDSS, such as assisting physicians in making clinical decisions in the face of uncertainty using knowledge-based reasoning. In comparison to non-knowledge-based systems, these systems may be integrated into clinical workflows and are less prone to errors.

Clinical Decision Support Systems Market Regional Insights:

North America dominates the Global Clinical Decision Support Systems market during the forecast period 2023-2030. North America is expected to hold the largest market shares of xx% by 2030. The clinical decision support systems (CDSS) market in North America is driven by technological advancements in CDSS, increased patient awareness, and rising investments in healthcare IT solutions in the region, all of which are expected to drives the market growth during the forecast period 2023-2030.

According to the Centers for Condition Control and Prevention (CDC), 6 out of 10 Americans had at least one chronic disease such as heart disease, stroke, cancer, or diabetes in 2019. Chronic diseases are the primary causes of death and disability in the United States, as well as a major contributor to healthcare spending. Besides, according to a study report published by the Organization for Economic Co-operation and Development (OECD), the average per capita health expenditure in 2030 is expected to be $1,500.

Asia Pacific is expected to grow rapidly at a CAGR of xx% during the forecast period 2023-2030. The CDSS market in Asia is expected to grow due to factors such as a large geriatric population, improved government laws, a high burden of chronic diseases, and an increasing focus of various industry players on emerging Asian countries.

Competitive Landscape:

Cerner Corporation dominates the Clinical Decision Support Systems Market

Cerner Corporation annual revenue was reached at USD 590 + Million in 2023 and is expected to dominate the Clinical Decision Support Systems market during the forecast period 2023-2030. Cerner is a multinational corporation established in the United States that provides medical offices, long-term care institutions, retail pharmacies, and laboratories with software, services, devices, and hardware. In Cerner Corporation, there are 26,400 employees are available in 2023. In Cerner Corporation, there are 56 health system member organizations, 991 settings of care, 22,000 plus hospital beds, and 26,000 plus affiliated physicians. The headquarters of the Cerner Corporation is in North Kansas City, Missouri, United States.

The objective of the report is to present a comprehensive analysis of the Global Clinical Decision Support Systems Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Global Clinical Decision Support Systems Market dynamic, structure by analyzing the market segments and project the Global Clinical Decision Support Systems Market size. Clear representation of competitive analysis of key players by Product Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Clinical Decision Support Systems Market make the report investor’s guide.

Clinical Decision Support Systems Industry Ecosystem

Clinical Decision Support Systems Market Scope: Inquire before buying

Clinical Decision Support Systems Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Clinical Decision Support Systems Market Key Players:

1. GE Healthcare
2. Optum, Inc.
3. Truven Health Analytics
4. First Databank, Inc.
5. Allscripts Healthcare Solutions
6. IBM
7. Elsevier B.V.
8. Hearst Health
9. Wolters Kluwer Health
10. Philips Healthcare
11. Meditech
12. Epic Systems
13. Mckesson
14. Cerner
15. NextGen Healthcare Information System LLC
16. Siemens Healthcare GmbH
17. Medical Information Technology, Inc.
18. Hearst Communications, Inc.
19. National Decision Support Company
20. Zynx Health Incorporated
21. VisualDx
22. EBSCO Industries, Inc.

Frequently Asked Questions:

1] What segments are covered in market report?
Ans. The segments covered in market report are based on Product, Delivery Mode, Model, Type, Component, Application, Level of Integrity, and Settings.

2] Which region is expected to hold the highest share in the market?
Ans. North America is expected to hold the highest share in the market.

3] Who are the top key players in the Clinical Decision Support Systems Market?
Ans. Cerner, Epic, Meditech, Wolters Kluwer Health, Zynx Health, and IBM are the top key
Players in the Clinical Decision Support Systems Market.

4] Which segment holds the largest market share in the Clinical Decision Support Systems market by 2030?
Ans. Cloud Based Delivery Mode segment hold the largest market share in the Clinical Decision Support Systems market by 2030.

5] What is the market size of the Clinical Decision Support Systems market by 2030?
Ans. The market size of the Clinical Decision Support Systems market is USD 2.8 Billion in
2030.

6] What was the market size of the Clinical Decision Support Systems market in 2023?
Ans. The market size of the Clinical Decision Support Systems market was worth USD 1.91
Billion in 2023.